Rachel A. Millstein, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Environment Design | 8 | 2021 | 174 | 1.340 |
Why?
|
| Health Behavior | 13 | 2022 | 2650 | 1.080 |
Why?
|
| Residence Characteristics | 11 | 2021 | 2116 | 1.000 |
Why?
|
| Exercise | 18 | 2024 | 5954 | 0.890 |
Why?
|
| Motor Activity | 10 | 2015 | 2713 | 0.880 |
Why?
|
| Environment | 6 | 2016 | 1120 | 0.850 |
Why?
|
| Patient Compliance | 4 | 2018 | 2697 | 0.700 |
Why?
|
| Behavioral Research | 2 | 2018 | 52 | 0.650 |
Why?
|
| Resilience, Psychological | 3 | 2020 | 807 | 0.600 |
Why?
|
| National Institutes of Health (U.S.) | 4 | 2018 | 793 | 0.590 |
Why?
|
| Behavioral Medicine | 1 | 2018 | 49 | 0.580 |
Why?
|
| Policy | 3 | 2020 | 513 | 0.570 |
Why?
|
| Mind-Body Therapies | 1 | 2020 | 294 | 0.550 |
Why?
|
| Maternal Deprivation | 2 | 2006 | 40 | 0.530 |
Why?
|
| Acute Coronary Syndrome | 6 | 2020 | 2193 | 0.530 |
Why?
|
| Spouses | 1 | 2018 | 286 | 0.520 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2018 | 263 | 0.510 |
Why?
|
| Health Promotion | 7 | 2024 | 2210 | 0.490 |
Why?
|
| Stress, Psychological | 10 | 2021 | 4526 | 0.440 |
Why?
|
| Parents | 4 | 2020 | 3594 | 0.430 |
Why?
|
| Public Facilities | 2 | 2015 | 34 | 0.410 |
Why?
|
| Social Support | 4 | 2018 | 2192 | 0.400 |
Why?
|
| Anxiety | 6 | 2023 | 4670 | 0.400 |
Why?
|
| Sports Equipment | 1 | 2011 | 27 | 0.390 |
Why?
|
| Play and Playthings | 1 | 2011 | 85 | 0.370 |
Why?
|
| Motivation | 1 | 2020 | 2021 | 0.350 |
Why?
|
| Emotions | 4 | 2017 | 2760 | 0.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2020 | 12250 | 0.340 |
Why?
|
| Schools | 2 | 2016 | 1498 | 0.330 |
Why?
|
| Depression | 8 | 2020 | 8234 | 0.300 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 5 | 2007 | 326 | 0.290 |
Why?
|
| Mice, Inbred Strains | 2 | 2006 | 1765 | 0.270 |
Why?
|
| Psychotherapy | 4 | 2020 | 1653 | 0.270 |
Why?
|
| Veterans | 4 | 2024 | 2666 | 0.250 |
Why?
|
| Societies, Medical | 1 | 2018 | 3964 | 0.250 |
Why?
|
| Body Size | 1 | 2008 | 462 | 0.250 |
Why?
|
| City Planning | 2 | 2015 | 14 | 0.240 |
Why?
|
| Obesity | 3 | 2016 | 13085 | 0.240 |
Why?
|
| Diet, Reducing | 1 | 2008 | 487 | 0.240 |
Why?
|
| Safety | 3 | 2014 | 1157 | 0.230 |
Why?
|
| Walking | 5 | 2021 | 1201 | 0.230 |
Why?
|
| Food | 1 | 2009 | 766 | 0.220 |
Why?
|
| Pilot Projects | 8 | 2021 | 8732 | 0.220 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 643 | 0.220 |
Why?
|
| Program Evaluation | 4 | 2024 | 2505 | 0.200 |
Why?
|
| Neural Inhibition | 1 | 2006 | 589 | 0.200 |
Why?
|
| Substance-Related Disorders | 5 | 2019 | 4422 | 0.200 |
Why?
|
| Quality of Life | 6 | 2024 | 13485 | 0.200 |
Why?
|
| Socioeconomic Factors | 6 | 2018 | 7848 | 0.190 |
Why?
|
| Social Environment | 1 | 2006 | 1012 | 0.190 |
Why?
|
| Mental Health | 5 | 2020 | 3272 | 0.180 |
Why?
|
| Feeding Behavior | 2 | 2014 | 3207 | 0.180 |
Why?
|
| Behavior Therapy | 2 | 2018 | 886 | 0.180 |
Why?
|
| Psychometrics | 3 | 2022 | 3060 | 0.170 |
Why?
|
| Physical Fitness | 1 | 2024 | 744 | 0.170 |
Why?
|
| Female | 42 | 2024 | 396660 | 0.160 |
Why?
|
| Psychotherapy, Group | 2 | 2020 | 417 | 0.160 |
Why?
|
| Humans | 57 | 2024 | 767040 | 0.160 |
Why?
|
| Research | 3 | 1998 | 1977 | 0.160 |
Why?
|
| Personnel, Hospital | 1 | 2020 | 285 | 0.150 |
Why?
|
| Chronic Disease | 4 | 2020 | 9362 | 0.150 |
Why?
|
| Prisoners | 1 | 2021 | 315 | 0.150 |
Why?
|
| Middle Aged | 26 | 2024 | 223233 | 0.150 |
Why?
|
| Male | 41 | 2024 | 364203 | 0.150 |
Why?
|
| Behavior, Animal | 6 | 2008 | 1865 | 0.140 |
Why?
|
| Happiness | 1 | 2019 | 170 | 0.140 |
Why?
|
| Individuality | 1 | 2019 | 303 | 0.140 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2023 | 454 | 0.140 |
Why?
|
| Contingent Negative Variation | 1 | 2016 | 35 | 0.140 |
Why?
|
| Heart Diseases | 2 | 2020 | 2817 | 0.140 |
Why?
|
| Qualitative Research | 4 | 2020 | 3139 | 0.130 |
Why?
|
| Ethanol | 3 | 2008 | 1330 | 0.130 |
Why?
|
| Women's Health | 2 | 2013 | 2082 | 0.130 |
Why?
|
| Genetics, Behavioral | 2 | 2006 | 53 | 0.130 |
Why?
|
| Weight Loss | 1 | 2008 | 2716 | 0.130 |
Why?
|
| Baltimore | 3 | 2014 | 233 | 0.130 |
Why?
|
| Hospitals, General | 1 | 2020 | 804 | 0.130 |
Why?
|
| Crime | 2 | 2014 | 206 | 0.130 |
Why?
|
| Central Nervous System Depressants | 2 | 2006 | 163 | 0.120 |
Why?
|
| Adolescent | 11 | 2020 | 89046 | 0.120 |
Why?
|
| Child | 12 | 2020 | 80771 | 0.120 |
Why?
|
| Aged | 19 | 2024 | 171319 | 0.110 |
Why?
|
| Program Development | 1 | 2020 | 1298 | 0.110 |
Why?
|
| Feasibility Studies | 6 | 2024 | 5311 | 0.110 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2014 | 62 | 0.110 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 2662 | 0.110 |
Why?
|
| Child Advocacy | 1 | 2014 | 48 | 0.110 |
Why?
|
| Depressive Disorder | 1 | 2006 | 3721 | 0.110 |
Why?
|
| Species Specificity | 3 | 2006 | 2412 | 0.110 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 1002 | 0.110 |
Why?
|
| Space Perception | 2 | 2015 | 468 | 0.110 |
Why?
|
| Adult | 19 | 2024 | 223317 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2024 | 2516 | 0.110 |
Why?
|
| Serotonin | 3 | 2008 | 1045 | 0.110 |
Why?
|
| Life Style | 1 | 2024 | 3931 | 0.100 |
Why?
|
| Gender Identity | 1 | 2018 | 769 | 0.100 |
Why?
|
| Self Efficacy | 1 | 2016 | 643 | 0.100 |
Why?
|
| Perception | 2 | 2020 | 1205 | 0.100 |
Why?
|
| Reference Values | 1 | 2019 | 4918 | 0.100 |
Why?
|
| Transportation | 3 | 2021 | 216 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1518 | 0.090 |
Why?
|
| Tobacco Industry | 1 | 2012 | 139 | 0.090 |
Why?
|
| Affect | 1 | 2019 | 1494 | 0.090 |
Why?
|
| Models, Psychological | 1 | 2015 | 823 | 0.090 |
Why?
|
| Data Collection | 2 | 2011 | 3321 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2020 | 1239 | 0.090 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2020 | 3724 | 0.090 |
Why?
|
| Smoke | 1 | 2012 | 243 | 0.090 |
Why?
|
| United States | 10 | 2022 | 72971 | 0.090 |
Why?
|
| Washington | 3 | 2015 | 315 | 0.080 |
Why?
|
| Public Policy | 1 | 2014 | 551 | 0.080 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 59548 | 0.080 |
Why?
|
| Young Adult | 6 | 2019 | 59980 | 0.080 |
Why?
|
| Telephone | 3 | 2020 | 629 | 0.080 |
Why?
|
| Counseling | 2 | 2018 | 1553 | 0.080 |
Why?
|
| Leisure Activities | 3 | 2015 | 310 | 0.080 |
Why?
|
| Public Health | 2 | 2019 | 2681 | 0.080 |
Why?
|
| Mice, Inbred DBA | 2 | 2006 | 624 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2008 | 69 | 0.080 |
Why?
|
| Desipramine | 1 | 2008 | 183 | 0.070 |
Why?
|
| Independent Living | 1 | 2012 | 584 | 0.070 |
Why?
|
| Conditioning, Operant | 2 | 2006 | 306 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 1907 | 0.070 |
Why?
|
| California | 3 | 2018 | 1439 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 6573 | 0.070 |
Why?
|
| Clinical Protocols | 1 | 2012 | 1443 | 0.070 |
Why?
|
| Receptors, Vasopressin | 1 | 2006 | 106 | 0.070 |
Why?
|
| Urban Health | 1 | 2009 | 533 | 0.070 |
Why?
|
| Reversal Learning | 1 | 2006 | 55 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2020 | 42606 | 0.060 |
Why?
|
| Linear Models | 2 | 2015 | 5875 | 0.060 |
Why?
|
| Alcoholic Intoxication | 1 | 2006 | 171 | 0.060 |
Why?
|
| Diet | 3 | 2022 | 8089 | 0.060 |
Why?
|
| Discrimination Learning | 1 | 2006 | 276 | 0.060 |
Why?
|
| Limbic System | 1 | 2007 | 418 | 0.060 |
Why?
|
| District of Columbia | 2 | 2014 | 159 | 0.060 |
Why?
|
| Maternal Behavior | 1 | 2006 | 307 | 0.060 |
Why?
|
| Extinction, Psychological | 1 | 2007 | 367 | 0.050 |
Why?
|
| Behavioral Symptoms | 1 | 2005 | 188 | 0.050 |
Why?
|
| Social Isolation | 1 | 2006 | 366 | 0.050 |
Why?
|
| Telemedicine | 1 | 2020 | 3110 | 0.050 |
Why?
|
| Antidepressive Agents | 2 | 2020 | 2912 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 8 | 2008 | 22361 | 0.050 |
Why?
|
| Acoustic Stimulation | 1 | 2006 | 1253 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2006 | 6611 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5716 | 0.050 |
Why?
|
| Self Report | 2 | 2024 | 3773 | 0.040 |
Why?
|
| Nortriptyline | 1 | 2000 | 79 | 0.040 |
Why?
|
| Poverty | 1 | 1992 | 2719 | 0.040 |
Why?
|
| Social Class | 1 | 2009 | 2007 | 0.040 |
Why?
|
| Consumer Advocacy | 1 | 2020 | 83 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2006 | 1411 | 0.040 |
Why?
|
| Mice | 10 | 2008 | 81912 | 0.040 |
Why?
|
| Dopamine | 1 | 2006 | 1581 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 4813 | 0.040 |
Why?
|
| Aging | 2 | 2018 | 8729 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2024 | 13048 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29963 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12069 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20169 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 39317 | 0.040 |
Why?
|
| Fear | 1 | 2007 | 1496 | 0.040 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2000 | 429 | 0.040 |
Why?
|
| Disabled Children | 1 | 2020 | 250 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6226 | 0.030 |
Why?
|
| Alcohol Drinking | 2 | 2006 | 4045 | 0.030 |
Why?
|
| Mice, Knockout | 6 | 2007 | 14476 | 0.030 |
Why?
|
| Overweight | 1 | 2008 | 2448 | 0.030 |
Why?
|
| Animals | 12 | 2008 | 168965 | 0.030 |
Why?
|
| Retirement | 1 | 2018 | 198 | 0.030 |
Why?
|
| Meditation | 1 | 2020 | 256 | 0.030 |
Why?
|
| Loneliness | 1 | 2018 | 211 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2016 | 6331 | 0.030 |
Why?
|
| Smoking | 1 | 2012 | 9081 | 0.030 |
Why?
|
| Neoplasms | 1 | 2024 | 22350 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2020 | 778 | 0.030 |
Why?
|
| Health Facilities | 1 | 2020 | 578 | 0.030 |
Why?
|
| Exploratory Behavior | 2 | 2006 | 271 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2008 | 10748 | 0.030 |
Why?
|
| Body Temperature | 2 | 2008 | 780 | 0.030 |
Why?
|
| Analysis of Variance | 3 | 2008 | 6215 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 3232 | 0.030 |
Why?
|
| Hippocampus | 1 | 2006 | 3777 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 283 | 0.030 |
Why?
|
| Heart Failure | 1 | 2017 | 11877 | 0.030 |
Why?
|
| Cities | 1 | 2015 | 542 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1587 | 0.030 |
Why?
|
| Bicycling | 1 | 2014 | 177 | 0.030 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 1997 | 597 | 0.030 |
Why?
|
| Sex Factors | 2 | 2014 | 10622 | 0.030 |
Why?
|
| Brain Chemistry | 2 | 2006 | 951 | 0.030 |
Why?
|
| Self Medication | 1 | 2012 | 115 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2005 | 3828 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2018 | 1432 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2022 | 2085 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2022 | 2191 | 0.020 |
Why?
|
| HIV Infections | 2 | 1998 | 17542 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2006 | 18330 | 0.020 |
Why?
|
| Fenclonine | 1 | 2008 | 16 | 0.020 |
Why?
|
| Research Design | 2 | 2017 | 6210 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3210 | 0.020 |
Why?
|
| Delivery of Health Care | 2 | 2020 | 5363 | 0.020 |
Why?
|
| Phenotype | 1 | 2006 | 16718 | 0.020 |
Why?
|
| Adrenergic Agents | 1 | 2008 | 72 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2024 | 41718 | 0.020 |
Why?
|
| Sleep | 3 | 2008 | 4816 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2013 | 2350 | 0.020 |
Why?
|
| Demography | 1 | 1992 | 1641 | 0.020 |
Why?
|
| Peer Group | 1 | 2012 | 702 | 0.020 |
Why?
|
| Educational Status | 1 | 2014 | 2511 | 0.020 |
Why?
|
| Fluvoxamine | 1 | 2006 | 77 | 0.020 |
Why?
|
| Caregivers | 1 | 2018 | 2302 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2006 | 144 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2006 | 152 | 0.020 |
Why?
|
| Risk-Taking | 1 | 1992 | 1023 | 0.020 |
Why?
|
| Hindlimb Suspension | 1 | 2006 | 77 | 0.020 |
Why?
|
| Tritium | 1 | 2006 | 707 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2008 | 898 | 0.020 |
Why?
|
| Income | 1 | 2014 | 1877 | 0.020 |
Why?
|
| Swimming | 1 | 2006 | 212 | 0.020 |
Why?
|
| Hypothermia | 1 | 2006 | 189 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 480 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 276 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 2006 | 292 | 0.010 |
Why?
|
| Reflex | 1 | 2006 | 375 | 0.010 |
Why?
|
| Dendrites | 1 | 2007 | 471 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2008 | 1759 | 0.010 |
Why?
|
| Benzazepines | 1 | 2006 | 307 | 0.010 |
Why?
|
| Rodentia | 1 | 2005 | 262 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2015 | 4525 | 0.010 |
Why?
|
| Dopamine Agonists | 1 | 2006 | 346 | 0.010 |
Why?
|
| Citalopram | 1 | 2006 | 402 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10092 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 10393 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 1531 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2018 | 8531 | 0.010 |
Why?
|
| Postural Balance | 1 | 2006 | 638 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 30211 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 2850 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1997 | 5130 | 0.010 |
Why?
|
| Risk Factors | 2 | 2015 | 74886 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2006 | 2086 | 0.010 |
Why?
|
| Reward | 1 | 2006 | 980 | 0.010 |
Why?
|
| Reaction Time | 1 | 2006 | 2086 | 0.010 |
Why?
|
| Brain | 1 | 2006 | 27163 | 0.010 |
Why?
|
| Amygdala | 1 | 2007 | 1375 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 2006 | 1193 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2006 | 1886 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 5519 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 2745 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 2591 | 0.010 |
Why?
|
| Time Factors | 2 | 2006 | 40154 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2015 | 24299 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 9327 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2006 | 5141 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 26325 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14672 | 0.010 |
Why?
|
| Pregnancy | 1 | 1992 | 30238 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 65295 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12451 | 0.000 |
Why?
|
| Comorbidity | 1 | 1997 | 10582 | 0.000 |
Why?
|
| Prevalence | 1 | 1997 | 15851 | 0.000 |
Why?
|